Use of a cholesterol emulsion in Smith-Lemli-Opitz syndrome (SLOS): A single-center observational study, retrospective analysis and structured caregiver interview

Overall, there was an improved effect on TC and 7-DHC levels compared to standard therapy, with high patient satisfaction and low side effects.

Authors

Institutions

Publication Details

Journal
Lipids in Health and Disease
Published
2025-10-22
DOI
https://doi.org/10.1186/s12944-025-02767-4
Primary Topic
Cholesterol and Lipid Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of a cholesterol emulsion in Smith-Lemli-Opitz syndrome (SLOS): A single-center observational study, retrospective analysis and structured caregiver interview

Manfred Fobker, Christiane Elpers, Thorsten Marquardt, Tobias Fischer et al.
Lipids in Health and Disease
Cholesterol and Lipid Metabolism
article

Use of a cholesterol emulsion in Smith-Lemli-Opitz syndrome (SLOS): A single-center observational study, retrospective analysis and structured caregiver interview

Manfred Fobker, Christiane Elpers, Thorsten Marquardt, Tobias Fischer, Ulrike Och, A.P. Born, Simone Harmeling
article en

Abstract

Overall, there was an improved effect on TC and 7-DHC levels compared to standard therapy, with high patient satisfaction and low side effects.

Lipids in Health and DiseaseVol. 24(1)
Augenstern (DE), University Hospital Münster (DE), Klinikum Osnabrück (DE)
Openalex Percentile: Top 53%
Cholesterol and Lipid Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.